Diabetes Pro Quarterly - Winter 2022 - 2

A Word from ADA's Chief Scientific & Medical Officer
Greetings, friends.
The newness of a fresh calendar is so exciting to me. It is a blank page-full of opportunity and just waiting to be filled up
with ideas, events, and memories. I welcome 2022 with a sense of expectation and an attitude of readiness. The American
Diabetes Association (ADA) impresses me every day. Our people are dedicated, disciplined, and devoted. With that strong
commitment and expectation in mind, I want to share a bit about how we are poised for our greatest year yet!
In late December 2021, we released our Standards of Medical Care in Diabetes-2022. It is stunning to watch how the
field of diabetes care is changing so rapidly and how the Association's talented team of volunteers and staff create such a
remarkable product. This year, there are a few notable updates, including:
* Guidance on first-line therapy determined by comorbidities;
* Screening for prediabetes and diabetes beginning at age 35 for all people;
* Changes to gestational diabetes mellitus recommendations regarding when to test and in whom testing should be done; and
* Updated recommendations on technology selection based on individual and caregiver considerations.
This spring, these guidelines are going visual! We are calling this new effort " Guidelines Insight. " The first few sections
will be available this month, with more to be added later. This project is part of a broader effort to ensure greater
implementation of the Standards of Care for all people affected by diabetes.
We recently reframed our former Advanced Postgraduate Course to become the 2022 Clinical Update Course. This latewinter
event focused on updates to the Standards of Care and was designed as an interdisciplinary, interactive event. This
year, because of the strain on health care professionals managing the COVID-19 pandemic, we held the event virtually on
February 4-6. Next year, we hope to offer both in-person and virtual attendance options.
The ADA's 82nd Scientific Sessions will happen in New Orleans, LA, on June 3-7, as our first hybrid conference. The
event will feature a robust schedule of onsite activities for those attending in person, as well as online sessions for those
attending virtually. We can't wait to showcase the incredible science and progress being made in diabetes every day.
This year will also bring a significant number of new research grants, made possible by successful fundraising and our continued
commitment to increasing ADA's research funding. We will continue to maximize the impact of our research funding through
a more targeted approach. Be on the lookout for the forthcoming 2021 Research Annual Report to learn more.
As I think about what the new year holds, my mind often goes to the many resolutions people are making. People are
committing themselves to a new and better year ahead. At the ADA, we, too, have resolutions. We insert our resolutions
into our strategy that is revised each year and continuously assessed. Our principles of Bending the Curve through cuttingedge
research and care, Helping People Living with Diabetes and Their Families Thrive, and Advocating for Change are our
resolutions and our commitment to you. Throughout the year, we will measure ourselves against these priorities and specific
targets in Advocacy, Communications, Development, Finance, Marketing, and Science & Health Care. With each passing
year, our goals deepen, our commitment grows, and our resolve strengthens. This
year, we are poised to make impressive progress, but that only happens through our
partnership with you. Thank you all for your continued support.
Won't you join us in a renewed commitment to do more for people with diabetes?
My warmest regards,
Robert Gabbay, MD, PhD,
ADA Chief Scientific & Medical Officer
2 DiabetesPro Quarterly | WINTER 2022

Diabetes Pro Quarterly - Winter 2022

Table of Contents for the Digital Edition of Diabetes Pro Quarterly - Winter 2022